Erratum: Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota (original) (raw)
- Erratum
- Open access
- Published: 10 July 2017
- N. Marungruang,
- N. Duthilleul,
- V. Cheatham,
- K. D. Mc Coy,
- G. Frisoni,
- J. J. Neher,
- F. Fåk,
- M. Jucker,
- T. Lasser &
- …
- T. Bolmont
Scientific Reports volume 7, Article number: 46856 (2017)Cite this article
- 1306 Accesses
- 35 Citations
- 2 Altmetric
- Metrics details
Subjects
This Article contains errors in the Discussion section.
“Our colonization experiments with microbiota from APPPS1 mice resulted in similar differences in Akkermansia and S24-7, along with increased AD-like pathology compared to colonization with microbiota from WT mice, indicating that these two microbial taxa may influence progression of AD pathology. Akkermansia can increase gut barrier integrity and thus control metabolic endotoxemia24. One can hypothesize that depleted in Akkermansia in AD mice may lead to a disturbed gut barrier with increased influx of inflammatory components including endotoxins. Consistent with this hypothesis, Kumar et al. showed that gastro-intestinal microbiota of the brains of transgenic 5XFAD mice resulted in seeding and accelerated cerebral beta-amyloid deposition29. The family of S24-7 bacteria in the Bacteroidales order have been linked to autoimmune diabetes and probiotic administration in mice can reduce disease together with decreased S24-7 abundance30. As Parabacteroides, also a member of the Bacteroidales order, was negatively correlated with AD-like pathology, our results suggest that a shift in Bacteroidales alleviate, from possibly protective Parabacteroides to S24-7 may affect cerebral Abeta amyloid progression”.
should read:
“Our colonization experiments with microbiota from APPPS1 mice resulted in similar differences in Akkermansia and S24-7, along with increased AD-like pathology compared to colonization with microbiota from WT mice, indicating that these two microbial taxa may influence progression of AD pathology. Akkermansia can increase gut barrier integrity and thus control metabolic endotoxemia24. One can hypothesize that gastro-intestinal microbiota depleted in Akkermansia in AD mice may lead to a disturbed gut barrier with increased influx of inflammatory components including endotoxins. Consistent with this hypothesis, Kumar et al. showed that bacterial infection of transgenic 5XFAD mice resulted in seeding and accelerated cerebral beta-amyloid deposition29. The family of S24-7 bacteria in the Bacteroidales order have been linked to autoimmune diabetes and probiotic administration in mice can alleviate disease together with decreased S24-7 abundance30. As Parabacteroides, also a member of the Bacteroidales order, was negatively correlated with AD-like pathology, our results suggest that a shift in Bacteroidales composition, from possibly protective Parabacteroides to S24-7 may affect cerebral Abeta amyloid progression”.
“Remarkably, in the brain pathogenicity of microbiota harvested from aged wild-type control mice was less pronounced compared to the microbiota harvested from aged APPPS1 mice that further hints to putative pathogenic gastro-intestinal microbiota strain(s) in the APPPS1 mouse model”.
should read:
“Remarkably, pathogenicity of microbiota harvested from aged wild-type control mice was less pronounced compared to the microbiota harvested from aged APPPS1 mice that further hints to putative pathogenic gastro-intestinal microbiota strain(s) in the APPPS1 mouse model”.
In addition, Figure 3 has duplicated panels for CONVR-APPPS1 at 3.5 month-old and GF-APPPS1 at 8 month-old. The correct Figure 3 appears below as Figure 1.
Authors
- T. Harach
You can also search for this author inPubMed Google Scholar - N. Marungruang
You can also search for this author inPubMed Google Scholar - N. Duthilleul
You can also search for this author inPubMed Google Scholar - V. Cheatham
You can also search for this author inPubMed Google Scholar - K. D. Mc Coy
You can also search for this author inPubMed Google Scholar - G. Frisoni
You can also search for this author inPubMed Google Scholar - J. J. Neher
You can also search for this author inPubMed Google Scholar - F. Fåk
You can also search for this author inPubMed Google Scholar - M. Jucker
You can also search for this author inPubMed Google Scholar - T. Lasser
You can also search for this author inPubMed Google Scholar - T. Bolmont
You can also search for this author inPubMed Google Scholar
Additional information
The online version of the original article can be found at 10.1038/srep41802
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Harach, T., Marungruang, N., Duthilleul, N. et al. Erratum: Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.Sci Rep 7, 46856 (2017). https://doi.org/10.1038/srep46856
- Published: 10 July 2017
- DOI: https://doi.org/10.1038/srep46856